jobs

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 1 Trial

Recent news which mentions Phase 1 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
KemPharm's SDX Higher Dose Shows Potential Against Sleep Disorders
Tickers KMPH
Tags KMPH Market News Benzinga
From Benzinga
Why Vallon Pharma Shares Are Staring At 52-Week Low Today
Tickers VLON
Tags Trading Ideas FDA Benzinga
From Benzinga
Adagene Shares Pop After FDA Clears Phase 1b/2 Trial For ADG126/Keytruda Combo Therapy In Solid Tumors
Tickers ADAG MRK
Tags ADAG Movers Briefs
From Benzinga
Sonnet Shares Surge As FDA Clears Its First Human Trial For Solid Tumor Candidate
Tickers SONN
Tags Briefs why it's moving News
From Benzinga
Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial
Tickers GSK IDYA
Tags Solid Tumor General GSK
From Benzinga
Cortexyme Posts Safety Data From SAD Portion Of COR588 Trial In P.Gingivalis
Tickers CRTX
Tags Biotech Phase 1 Trial Health Care
From Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
Tickers NTLA REGN
Tags Health Care REGN Phase 1 Trial
From Benzinga
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
Tickers ALKS
Tags Benzinga Trading Ideas Phase 2 Trial
From Benzinga
Enanta Pharma Commences Dosing In Phase 1 COVID-19 Trial
Tickers ENTA
Tags Trading Ideas Benzinga Market News
From Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
Tickers AMGN
Tags Market News Phase 2 Trial AMGN
From Benzinga
FDA Slams Brakes On Legend Biotech's CAR-T Therapy Trial In Lymphoma Patients
Tickers LEGN
Tags General LEGN News
From Benzinga
Moleculin Biotech Annamycin Doublet Therapy Shows 68% Overall Survival In Animal Study
Tickers MBRX
Tags acute myeloid leukemia General MBRX
From Benzinga
Avalon GloboCare Adds CAR-NK Cell Therapies To Expand Cellular Immuno-Oncology Platform
Tickers AVCO
Tags General Health Care AVCO
From Benzinga
UNITY Biotech Stock Jumps On Additional Data From UBX1325 Trial In Vascular Eye Disease
Tickers UBX
Tags UBX why it's moving Briefs
From Benzinga
Pardes Biosciences Shares Early Data From COVID-19 Study
Tickers PRDS
Tags Briefs News COVID/19 Coronavirus
From Benzinga
FDA Clears Cidara Therapeutics' Phase 1 Trial For Immunotherapeutic Antiviral For Influenza
Tickers CDTX
Tags Market News FDA Benzinga
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
Tickers RGNX
Tags Health Care Phase 1 Trial gene therapy
From Benzinga
Why Did IGM Biosciences Shares Advance Today?
Tickers IGMS
Tags Benzinga Trading Ideas Market News
From Benzinga
4D Molecular Shares Updated Data From Fabry Disease Trial
Tickers FDMT
Tags Benzinga Trading Ideas Phase 2 Trial
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Tickers AVRO
Tags AVRO Fabry disease News
From Benzinga
CAR-T Player Arcellx Raises $123M Via Initial Public Offering, Opens Trading At $19
Tickers ACLX
Tags Phase 1 Trial Small Cap Biotech
From Benzinga
Pardes Biosciences Clears IND Application For Oral Antiviral Candidate For COVID-19
Tickers PRDS
Tags Phase 1 Trial Biotech Small Cap
From Benzinga
Viridian Therapeutics To Test Next-Gen IGF-1R Antibody In Thyroid Eye Disease
Tickers VRDN
Tags VRDN Phase 1 Trial Briefs
From Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
Tickers TSHA
Tags Biotech Phase 1 Trial gene therapy
From Benzinga
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
Tickers LBPS
Tags Movers News Briefs
From Benzinga
Sellas Life Sciences Shares Jump As China Approves Galinpepimut IND For Blood Cancer
Tickers SLS
Tags General Briefs News
From Benzinga
Vaccinex Posts Two Complete Responses In Pepinemab Combo Trial In Head & Neck Cancer
Tickers MRK VCNX
Tags Benzinga Trading Ideas Penny Stocks
From Benzinga
Two Organizations To Support Wave Life Sciences' FTD, ALS Program
Tickers WVE
Tags General News Briefs
From Benzinga
89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health
Tickers ETNB
Tags Biotech Phase 1 Trial Briefs
From Benzinga
Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA
Tickers TNGX
Tags General Briefs News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News Instagram Instagram
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

922 Allowance Ave SE
Medicine Hat, AB T1A 3G7

Office hours: 8:30 a.m.-4:30 p.m. Monday to Friday, closed Saturday Sunday and statutory holidays.

[P] 403.527.1101
[F] 403-527-0737

Print Advertising: 403.528.5659
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2024 The Medicine Hat News